Position in CGC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$64,431
+$43,113 QoQ
Shares Held
67,823
+201.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 212 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Dec 31, 2024CallValue
$197,280
CallShares
72,000
PutValue
$89,050
PutShares
32,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $151,394,819 across 40 Drug Manufacturers - Specialty & Generic names. CGC ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
633,370 | $45,513,968 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
48,656 | $26,363,280 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
617,308 | $21,402,068 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
140,059 | $8,956,773 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
44,143 | $7,439,861 | |
| 6 | ALKS |
Alkermes plc.
|
115,195 | $6,036,218 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
133,225 | $3,278,667 | |
| 8 | HROW |
Harrow, Inc.
|
73,622 | $3,126,726 |
All Filings in CGC
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,431 | 67,823 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,318 | 22,464 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $50,433 | 41,339 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $197,280 | 72,000 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $89,050 | 32,500 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $378,665 | 138,199 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $588,414 | 91,227 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $293,117 | 33,965 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $144,633 | 28,304 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $49,312 | 62,979 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $20,640 | 53,197 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $308,358 | 176,205 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $128,364 | 55,569 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $154,979 | 56,769 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $125,995 | 44,209 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $278,709 | 36,769 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $356,306 | 40,814 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $1,754,635 | 54,781 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||